BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu B, Yang XB, Sang XT. Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma. J Hepatocell Carcinoma 2020;7:315-30. [PMID: 33204664 DOI: 10.2147/JHC.S272109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lederer M, Müller S, Glaß M, Bley N, Ihling C, Sinz A, Hüttelmaier S. Oncogenic Potential of the Dual-Function Protein MEX3A. Biology (Basel) 2021;10:415. [PMID: 34067172 DOI: 10.3390/biology10050415] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Liu Y, Zeng S, Qian W, Tao M, Zhu Y, Li J. DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma. PGPM 2022;Volume 15:261-75. [DOI: 10.2147/pgpm.s356326] [Reference Citation Analysis]
3 Yang Y, Li J, Tang M, Nie B, Huang W. Decaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma. CMAR 2022;Volume 14:1627-39. [DOI: 10.2147/cmar.s364346] [Reference Citation Analysis]
4 Viet CT, Yu G, Asam K, Thomas CM, Yoon AJ, Wongworawat YC, Haghighiabyaneh M, Kilkuts CA, McGue CM, Couey MA, Callahan NF, Doan C, Walker PC, Nguyen K, Kidd SC, Lee SC, Grandhi A, Cheng AC, Patel AA, Philipone E, Ricks OL, Allen CT, Aouizerat BE. The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma. Biomark Res 2021;9:42. [PMID: 34090518 DOI: 10.1186/s40364-021-00292-x] [Reference Citation Analysis]
5 Li H, Liu L, Huang T, Jin M, Zheng Z, Zhang H, Ye M, Liu K. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma. Aging (Albany NY) 2021;13:23072-95. [PMID: 34610581 DOI: 10.18632/aging.203599] [Reference Citation Analysis]
6 Cai C, Yang L, Zhou K. 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma. BMC Gastroenterol 2021;21:463. [PMID: 34895169 DOI: 10.1186/s12876-021-02057-0] [Reference Citation Analysis]
7 Zeng Z, Lei S, Wang J, Yang Y, Lan J, Tian Q, Chen T, Hao X. A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma. Bioengineered 2022;13:12193-210. [PMID: 35549979 DOI: 10.1080/21655979.2022.2073943] [Reference Citation Analysis]
8 Hassan Venkatesh G, Abou Khouzam R, Shaaban Moustafa Elsayed W, Ahmed Zeinelabdin N, Terry S, Chouaib S. Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity? Oncoimmunology 2021;10:1974233. [PMID: 34595058 DOI: 10.1080/2162402X.2021.1974233] [Reference Citation Analysis]
9 Milosa F, Critelli RM, Lasagni S, Pivetti A, Di Marco L, Romagnoli D, Carulli L, Dituri F, Mancarella S, Giannelli G, Martinez‐chantar M, Fabris L, Villa E. Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma. Liver Cancer International 2021;2:15-26. [DOI: 10.1002/lci2.23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]